@karolinskainstitutet
  @karolinskainstitutet
Karolinska Institutet | Emelie Foord explains new findings about the role of certain T cells in ovarian cancer @karolinskainstitutet | Uploaded 3 years ago | Updated 5 hours ago
A study from Karolinska Institutet published in Science Translational Medicine (January 2021) shows that a subset of immune cells called gamma delta T cells are associated with increased survival in patients with advanced ovarian cancer. PhD student Emelie Foord in Michael Uhlin's research group explains the results and potential clinical implications.
Emelie Foord explains new findings about the role of certain T cells in ovarian cancerNobel Calling: Frukostsamtal om covid-19 – antikroppssvar och vaccinMeet Marie Hasselberg, Professor of Public Health EpidemiologyBjörn Högberg: The art of folding DNAHagströmerbiblioteket: 1900 - tal laboratorievetenskapHagströmer Library Mini Tours: Lungs and Epidemics Part 1.Experimental approaches to alleviating global poverty – implications for global healthMieke Rijken - International symposium “Multimorbidity research at the cross-roads”Maria Bradley: Studying genetic causes of atopic dermatitisChristian Rück: Developing online treatments for OCDWeight-loss surgery cuts risk of major birth defects, study findsVårdforskningens framtid

Emelie Foord explains new findings about the role of certain T cells in ovarian cancer @karolinskainstitutet

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER